(NYSE: BMY) Bristol Myers Squibb Co's forecast annual revenue growth rate of -4.33% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Bristol Myers Squibb Co's revenue in 2025 is $48,300,000,000.On average, 9 Wall Street analysts forecast BMY's revenue for 2025 to be $92,990,368,211,959, with the lowest BMY revenue forecast at $92,161,205,524,545, and the highest BMY revenue forecast at $94,419,953,594,177. On average, 9 Wall Street analysts forecast BMY's revenue for 2026 to be $87,103,697,280,088, with the lowest BMY revenue forecast at $83,210,005,568,757, and the highest BMY revenue forecast at $90,286,121,215,293.
In 2027, BMY is forecast to generate $86,753,561,812,951 in revenue, with the lowest revenue forecast at $81,995,651,049,010 and the highest revenue forecast at $93,445,760,035,104.